About this trial

This study investigates whether alteplase can help to improve pleural fluid drainage and dyspnea (breathlessness) in patients with non-draining malignant pleural effusion. Alteplase helps dissolve blood clots and is used to treat heart attacks, strokes, and clots in the lungs. Alteplase may help to control symptoms of breathlessness.

Eligibility criteria

Qualifiers

Referral to pulmonary services for inability to drain fully via IPC

Presence of a symptomatic septated pleural effusion

Chest radiograph: effusion filling >= 1/3 of the hemithorax, or

Computed tomography (CT)-scan: AP depth of the effusion >= 1/3 of the AP dimension on the axial image superior to the hemidiaphragm, including atelectatic lung surrounded by effusion, or

Disqualifiers

Inability to provide informed consent

Uncorrectable coagulopathy based on criteria followed by cardiopulmonary center for procedures.

Active bleeding

Known allergic reaction to thrombolytics

Trial design

Treatments tested in this trial

  • Alteplase
  • Placebo Administration

Treatment groups

30 Participants
are divided into 2 treatment groups

Locations

1
M D Anderson Cancer Center77030, HoustonTexas, United States

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor